LUNDBECK PHARMA A/S: Financial statements 2013
CVR: 56750215
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
LUNDBECK PHARMA A/S (CVR 56750215) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 33,008,000 and a net result of DKK -89,000 compared with DKK 691,000 the year before. That is a decrease of 24.6% compared with the year before. The profit margin was -0.3%. Equity in the 2013 report amounted to DKK 2,971,000. The solvency ratio was 12.3%.
- Revenue
- DKK 33,008,000
- Gross Profit
- DKK 24,303,000
- Profit/Loss
- DKK -89,000
- Equity
- DKK 2,971,000
- Total Assets
- DKK 24,076,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 33 mio. | 24.3 mio. | -89 t. | 3 mio. | - |
| 2012 | 43.8 mio. | 28.4 mio. | 691 t. | 3 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
LUNDBECK PHARMA A/S has published its annual report for 2012. Revenue came to DKK 43,784,000, and the net result was DKK 691,000.
As of January 14, 2013, Ole Chrintz has left the board of directors of LUNDBECK PHARMA A/S.
As of January 14, 2013, Michael Quiqueran-Beaujeu has left the board of directors of LUNDBECK PHARMA A/S.
As of January 14, 2013, Leif-Petter Jokinen has left the board of directors of LUNDBECK PHARMA A/S.
About LUNDBECK PHARMA A/S
LUNDBECK PHARMA A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1958. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANS LUNDBECK A/S. The management consists of Søren Klein-Kristensen. The board consists of Michala Fischer-Hansen (chair), Søren Klein-Kristensen and Thomas Bo Bjørn Klee. The company is owned by H. LUNDBECK A/S. The company has 18 employees (2026). In 2025, the company reported revenue of DKK 18,887,000 and a net result of DKK 2,291,000 compared with DKK 1,820,000 the year before. Equity in the 2025 report amounted to DKK 3,378,000.